that’s the first thing that came to my mind when I heard that
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.18%
!
$13.13

Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-147
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.13 |
Change
0.280(2.18%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.733M | 360.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 114 | $13.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.14 | 546 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12 | 13.140 |
7 | 129 | 13.130 |
9 | 742 | 13.120 |
12 | 1779 | 13.110 |
5 | 1322 | 13.100 |
Price($) | Vol. | No. |
---|---|---|
13.150 | 231 | 1 |
13.160 | 803 | 6 |
13.170 | 1154 | 7 |
13.180 | 6765 | 13 |
13.190 | 2485 | 10 |
Last trade - 13.01pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online